Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravin Ratan

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
The Oncologist|December 8, 2020
Evaluating the Soft Tissue Sarcoma Paradigm for the Local Management of Extraskeletal Ewing SarcomaDavid Boyce-Fappiano, B Ashleigh Guadagnolo, Ravin Ratan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2022
Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II StudyVivek Subbiah, Irene Braña, Alessandra Longhi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2025
Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi TrialRavin Ratan, Bernd Kasper, Thierry Alcindor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2026
Reply to: In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid TumorsRavin Ratan, Bernd Kasper, Thierry Alcindor, et al.
Cancers|May 11, 2024
Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal TumorsRyan A Denu, Cissimol P Joseph, Elizabeth S Urquiola, et al.
Nature Communications|March 26, 2026
Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket studyMrinal Gounder, Patrick Schöffski, Robin L Jones, et al.
Sarcoma|June 23, 2020
PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated LiposarcomaAmanda Parkes, Elizabeth Urquiola, Priya Bhosale, et al.
Leukemia & Lymphoma|January 12, 2017
Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplantJenna D Goldberg, Junting Zheng, Ravin Ratan, et al.
Cancer|April 20, 2024
Safety and efficacy of percutaneous image-guided ablation for soft tissue sarcoma metastases to the liverAhmed Awad, Koustav Pal, Steven Yevich, et al.
Cancer Medicine|September 24, 2022
Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcomaPrapassorn Thirasastr, Heather Lin, Behrang Amini, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
The Oncologist|December 8, 2020
Evaluating the Soft Tissue Sarcoma Paradigm for the Local Management of Extraskeletal Ewing SarcomaDavid Boyce-Fappiano, B Ashleigh Guadagnolo, Ravin Ratan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2022
Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II StudyVivek Subbiah, Irene Braña, Alessandra Longhi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2025
Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi TrialRavin Ratan, Bernd Kasper, Thierry Alcindor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2026
Reply to: In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid TumorsRavin Ratan, Bernd Kasper, Thierry Alcindor, et al.
Cancers|May 11, 2024
Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal TumorsRyan A Denu, Cissimol P Joseph, Elizabeth S Urquiola, et al.
Nature Communications|March 26, 2026
Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket studyMrinal Gounder, Patrick Schöffski, Robin L Jones, et al.
Sarcoma|June 23, 2020
PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated LiposarcomaAmanda Parkes, Elizabeth Urquiola, Priya Bhosale, et al.
Leukemia & Lymphoma|January 12, 2017
Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplantJenna D Goldberg, Junting Zheng, Ravin Ratan, et al.
Cancer|April 20, 2024
Safety and efficacy of percutaneous image-guided ablation for soft tissue sarcoma metastases to the liverAhmed Awad, Koustav Pal, Steven Yevich, et al.
Cancer Medicine|September 24, 2022
Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcomaPrapassorn Thirasastr, Heather Lin, Behrang Amini, et al.
Pageof 6